-
‘Pioneering’ drug for rare eye cancer to be rolled out on NHS in England | Science, Climate & Tech News
admin
Hundreds of people in England with a rare form of eye cancer are set to have access to a “pioneering” drug, the NHS has announced. Following approval by the National Institute for Health and Care Excellence (NICE), patients diagnosed with uveal melanoma can now be offered a drug called tebentafusp. The cancer is thought to…
-
Pioneering Alzheimer’s drug rejected for widespread use in NHS in England | UK News
admin
A new pioneering Alzheimer’s drug has been rejected for widespread use in the NHS in England. The announcement comes as the UK’s medicines regulator said that donanemab could be licensed for use in the UK. However, the health spending watchdog, the National Institute of Health and Care Excellence (NICE), said that it “does not currently…
-
Men taking epilepsy drug valproate warned to use effective contraception | UK News
admin
Thousands of men taking a drug for epilepsy or bipolar disorder – and their partners – have been warned to use effective contraception because any babies they conceive may be at increased risk of harm. The Medicines and Healthcare products Regulatory Agency (MHRA) says new evidence shows children born to men taking the drug valproate…
-
Alzheimer’s drug lecanemab that slows decline given green light in UK – but won’t be available on NHS | UK News
admin
A drug that can slow the debilitating symptoms of Alzheimer’s has been approved by the UK’s medicines regulator. In an unusual double-header assessment by UK authorities, the Medicines and Healthcare products Regulatory Agency (MHRA) has said the drug lecanemab is safe and effective enough for doctors to prescribe, but a separate NHS watchdog has ruled…
-
drug, experimental, extends, humans, lifespan, Mice, middleaged, News, Science, scientists, Tech, work
Experimental drug extends the lifespan of ‘middle-aged’ mice by 25% – and could work on humans too, scientists say | Science & Tech News
admin
An experimental drug that extends the lifespan of mice by 25% could also work in humans, according to the scientist who ran the trials. The treatment – an injection of an antibody called anti-IL-11 that was given to the mice when they were ‘middle-aged’ – reduced deaths from cancer. It also lowered the incidence of…
-
Obesity drug shows significant weight loss for at least four years, with fewer serious events, study finds | Science & Tech News
admin
The largest and longest study of the obesity drug Wegovy has shown people maintain significant weight loss for at least four years, with fewer serious adverse events than those given placebo ‘dummy’ treatment. Doctors say the finding will add pressure on UK health authorities, which currently limit treatment to just two years. Results revealed at…
-
Mounjaro: New weight loss drug approved for use in Britain to be available ‘within weeks’ | UK News
admin
An American weight loss drug approved in a four-dose injection pen format for use in Britain could be available “within weeks”. Mounjaro, also known as tirzepatide, is a diabetes drug that was authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) to help obese and overweight adults lose and manage weight in November last…
-
Blinatumomab: The new cancer drug helping unwell children that is kinder and more targeted than chemotherapy | UK News
admin
An 11-year-old boy, who is now free of blood cancer after undergoing a new type of treatment, has told Sky News the drug gave him a “burst of energy”. Arthur D’Hulst had leukaemia but traditional chemotherapy failed to clear it, leaving him very weak, and the side effects were rough. He was offered a new…
-
World-first trial finds arthritis drug may help treat type 1 diabetes | Science & Tech News
admin
A world-first clinical trial has found a common drug used to treat rheumatoid arthritis can suppress the progression of type 1 diabetes in recently diagnosed patients. Researchers at St Vincent’s Institute of Medical Research in Melbourne, Australia, discovered baricitinib can preserve the body’s own insulin production. They described the finding as “a huge step-change” in…
-
‘Repurposed’ drug that could prevent breast cancer to be offered to nearly 300,000 women | UK News
admin
A “repurposed” drug that could prevent breast cancer as well as treat it will be offered to almost 300,000 women, NHS officials have revealed. Anastrozole has been used to treat hormone-sensitive breast cancer. But trials have shown it can also stop the disease from occurring in the first place. It’s predicted cases could be cut…